arcadia

ASTRAZENECA PHARMA INDIA LTD.

NSE : ASTRAZENBSE : 506820ISIN CODE : INE203A01020Industry : Pharmaceuticals & DrugsHouse : Astrazeneca Pharma India - MNC
BSE1012.20-6.15 (-0.6 %)
PREV CLOSE ( ) 1018.35
OPEN PRICE ( ) 1017.95
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 932
TODAY'S LOW / HIGH ( )999.85 1030.00
52 WK LOW / HIGH ( )882.55 1278
NSE1001.55-14.2 (-1.4 %)
PREV CLOSE( ) 1015.75
OPEN PRICE ( ) 1019.45
BID PRICE (QTY) 1001.55 (3)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 2506
TODAY'S LOW / HIGH( ) 995.00 1035.00
52 WK LOW / HIGH ( )880.2 1278
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 11-07 1979
Management Info
Narayan K Seshadri - Chairman Gagan Singh Bedi - Managing Director
Registered Office

Address Block N1, 12th Floor,Manyata Embassy Business Park,Rachenahalli, Outer Ring Road,
Bengaluru,
Karnataka-560045

Phone

Email comp.secy@astrazeneca.com

Website www.astrazenecaindia.com

Registrars Details
Integrated Registrary Management Services Pvt Ltd.-(Formerly Integrated Enterprises (India) Ltd)
30, Ramana Residency,4th Cross, Sampige Road,Malleswaram,Bangalore
Listing : BSE, NSE, MCX
NEWS
18Apr AstraZeneca strengthens innovation par
AstraZeneca Pharma India’s parent company - AstraZeneca will be further..
18Apr AstraZeneca soars on strengthening inn
AstraZeneca Pharma India is currently trading at Rs. 1020.00, up by 25.4..
17Apr Announcement under Regulation 30 (LOD
Please find enclosed a copy of the News Release being issued titled:..
16Feb Announcement under Regulation 30 (LOD
We refer to our earlier communication dated October 17, 2017 and Decembe..
14Feb JSW Steel, AstraZeneca Pharma and Prec
JSW Steel has obtained all the required clearances and final commencemen..
Financials
Rs. in Millions
QTR Dec 17 ANNUAL 17
Net Profit-103.52244.42
Gross Profit -118.16 332.05
Operating Profit -80.86490.31
Net Sales 1285.395395.71
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Zandu Realty (BSE)
 2099.45 (3.61%)
M.Cap ( in Cr)165.99
Sanofi India (BSE)
 4960.90 (0.55%)
M.Cap ( in Cr)11653.49
Mercury Laboratories (BSE)
 425.25 (5.00%)
M.Cap ( in Cr)48.96
Gufic Biosciences (BSE)
 132.90 (12.15%)
M.Cap ( in Cr)953.73
Jenburkt Pharma (BSE)
 729.40 (1.85%)
M.Cap ( in Cr)339.59
Shareholding Pattern
PROMOTERS 75%
NON-INSTITUTION 17.08%
MUTUAL FUNDS/UTI 7.71%
FI/BANKS/INSURANCE 0.08%
GOVERNMENT 0%
FII 0%
Attention Investors

"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."

"Prevent Unauthorized Transactions in your demat account -> Update your Mobile Number and Email address with your Depository Participant. Receive alerts on your Registered Mobile and Email address for all debit and other important transactions in your demat account directly from CDSL on the same day..... issued in the interest of investors."

ARCADIA SHARE & STOCK BROKERS PVT. LTD.

MEMBER NSE (CASH & DERIVATIVES) : INB/F_230778238

MEMBER BSE (CASH) : INB010778232

MEMBER CDSL DP : IN225

ARCADIA COMMODITIES & TRADING

MEMBER MCX : 10950

MEMBER NCDEX : 00374 & FMC – MCX/TCM/PART/0503 & FMC –NCDEX/TCM/PART/0356 & ACE COMMODITY EXCHANGE MEMBER ID –

6090 FMC – ACE/TCM/PART/0252 & NSEL MEMBER - 14120 SEBI- NCDEX - INZ000048620

Copyright © 2017 Arcadia Share & Stock Brokers Pvt. Ltd.

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

GO TO TOP
CLOSE X
Exclusive Email address for the Customer Grievance dphelp@arcadiashare.com
CLOSE

COMPLAINTS FORM